What: 

Stellar Biotechnologies, Inc. (Nasdaq:SBOT), which specializes in manufacturing Keyhole Limpet Hemocyanin (KLH) protein, an immune-stimulating molecule widely used in immunotherapy development, will visit the Nasdaq MarketSite in Times Square.

In honor of the occasion, Frank Oakes, Chairman, President and Chief Executive Officer will ring the Closing Bell. 

Where:

Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When:

Thursday, November 5, 2015 – 3:45 p.m. to 4:00 p.m. ET           

Stellar Biotechnologies, Inc. Media Contacts:

Mark A. McPartland(805) 488-2800 ext. 103markmcp@stellarbiotech.com

Joanna ZimmermanThe Ruth Group(646) 536-7006jzimmerman@theruthgroup.com

Nasdaq MarketSite:

Will Briganti(646) 441-5012William.Briganti@nasdaq.com

Feed Information:

Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK

Social Media:

For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at: http://www.facebook.com/NASDAQ.

For photos from ceremonies and events visit our Instagram Page: http://instagram.com/nasdaq

For news tweets, please visit our Twitter page at: http://twitter.com/nasdaq

For exciting viral content and ceremony photos visit Tumblr Page: http://nasdaq.tumblr.com/

Webcast:

A webcast of the Nasdaq Closing Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx

Photos:

To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.

About Stellar Biotechnologies, Inc. (Nasdaq:SBOT):

Stellar Biotechnologies, Inc. (OTCQB:SBOTF) (TSX VENTURE:KLH) is the leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets. KLH is both an active pharmaceutical ingredient (API) in many new immunotherapies (targeting cancer, immune disorders, Alzheimer's, and inflammatory diseases) as well as a finished product for measuring immune status. Stellar Biotechnologies is unique in its proprietary methods, facilities, and KLH technology. We are committed to meeting the growing demand for commercial-scale supplies of GMP grade KLH, ensuring environmentally sound KLH production, and developing KLH-based active immunotherapies.

About Nasdaq:

Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,600 listed companies with a market value of approximately $8.8 trillion and more than 10,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.

-NDAQA-

 

Stellar Biotechnologies, Inc. (TSXV:KLH)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Stellar Biotechnologies, Inc. Charts.
Stellar Biotechnologies, Inc. (TSXV:KLH)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Stellar Biotechnologies, Inc. Charts.